Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis

Abstract: Background and Aims: Congenital hepatic fibrosis (CHF) is characterized by dense portal/septal fibrosis and bile duct proliferation and tortuosity. In this study, the roles and significance of fibrosis‐related cells and molecules in the process of progressive and unresolving fibrosis of CHF were examined in comparison with other fibrotic liver diseases.

[1]  F. Marumo,et al.  Phenotypic change in portal fibroblasts in biliary fibrosis. , 2008, Liver.

[2]  R. Coffey,et al.  PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. White,et al.  Cytokine regulation of pulmonary fibrosis in scleroderma. , 2003, Cytokine & growth factor reviews.

[4]  W. Hornebeck.  Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. , 2003, Pathologie-biologie.

[5]  N. LaRusso,et al.  Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. , 2003, Gastroenterology.

[6]  D. Brigstock,et al.  Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  H. Ninomiya,et al.  Smad expression of hepatic stellate cells in liver cirrhosis in vivo and hepatic stellate cell line in vitro , 2003, Pathology international.

[8]  M. Kasuga,et al.  Histological grading and staging in chronic hepatitis:   Its practical correlation , 2002, Pathology international.

[9]  V. Paradis,et al.  Effects and Regulation of Connective Tissue Growth Factor on Hepatic Stellate Cells , 2002, Laboratory Investigation.

[10]  P. Lewindon,et al.  The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. , 2002, The American journal of pathology.

[11]  M. Gaca,et al.  Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. , 2002, Journal of hepatology.

[12]  A. Baird,et al.  Mast cell hyperplasia in chronic rejection after liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  Y. Nakanuma,et al.  Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis. , 2001, The American journal of pathology.

[14]  T. Roskams,et al.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. , 2001, Journal of hepatology.

[15]  K. Tsuneyama,et al.  Enhanced expression of basement‐membrane‐type heparan sulfate proteoglycan in tumor fibro‐myxoid stroma of intrahepatic cholangiocarcinoma , 2001, Pathology international.

[16]  D. Schuppan,et al.  Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. , 2001, The American journal of pathology.

[17]  K. Fang,et al.  Mast Cell Tissue Inhibitor of Metalloproteinase-1 Is Cleaved and Inactivated Extracellularly by α-Chymase1 , 2001, The Journal of Immunology.

[18]  K. Tsuneyama,et al.  Evidence of the Participation of Peribiliary Mast Cells in Regulation of the Peribiliary Vascular Plexus Along the Intrahepatic Biliary Tree , 2000, Laboratory Investigation.

[19]  M. Arthur,et al.  Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. , 2000, Journal of hepatology.

[20]  K. Tsuneyama,et al.  Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c‐kit‐expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis , 1999, The Journal of pathology.

[21]  Gary R. Grotendorst,et al.  Connective tissue growth factor mediates transforming growth factor b-induced collagen synthesis : down-regulation by cAMP , 1999 .

[22]  N. Kawada,et al.  In Vitro Migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation , 1999, Hepatology.

[23]  M. Arthur,et al.  Human and rat hepatic stellate cells produce stem cell factor: a possible mechanism for mast cell recruitment in liver fibrosis. , 1999, Journal of hepatology.

[24]  S. Crawford,et al.  Increased expression of transforming growth factor-beta1 and thrombospondin-1 in congenital hepatic fibrosis: possible role of the hepatic stellate cell. , 1999, Journal of pediatric gastroenterology and nutrition.

[25]  K. Toyoshima,et al.  Basement membrane heparan sulfate proteoglycan (perlecan) synthesized by ACC3, adenoid cystic carcinoma cells of human salivary gland origin. , 1999, Journal of biochemistry.

[26]  Gary R. Grotendorst,et al.  Inhibition of TGF‐β‐stimulated CTGF gene expression and anchorage‐independent growth by cAMP identifies a CTGF‐dependent restriction point in the cell cycle , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Y. Nakanuma,et al.  Relationship between interleukin‐6 and proliferation and differentiation in cholangiocarcinoma , 1998, Histopathology.

[28]  Pieter,et al.  Localization and cellular sources of activins in normal and fibrotic rat liver , 1997, Hepatology.

[29]  Y. Nakanuma,et al.  Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply , 1997, Microscopy research and technique.

[30]  Gary R. Grotendorst,et al.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.

[31]  T. Roskams,et al.  Heparan sulfate proteoglycan expression in normal human liver , 1995, Hepatology.

[32]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[33]  Y. Nakanuma,et al.  Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey. , 1994, Human pathology.

[34]  J. Hoofnagle,et al.  Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.

[35]  E. Wisse,et al.  Tissue distribution, quantitation and proliferation kinetics of fat‐storing cells in carbon tetrachloride–injured rat liver , 1991, Hepatology.

[36]  K. Austen,et al.  A single gene in mast cells encodes the core peptides of heparin and chondroitin sulfate proteoglycans. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Tsuneyama,et al.  Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study. , 2002, Pathology, research and practice.

[38]  S. Friedman.  Cytokines and Fibrogenesis , 1999, Seminars in liver disease.

[39]  L. Rubbia‐Brandt,et al.  Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[40]  W. Border,et al.  Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.

[41]  P. van Eyken,et al.  Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study. , 1993, Journal of hepatology.

[42]  S. Sherlock,et al.  Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. , 1986, Journal of hepatology.